Covid-19 &
Influenza Vaccine
Clinical Trial
Researchers at Trialmed are conducting a clinical research study to evaluate an investigational vaccine designed to protect against both COVID-19 and seasonal influenza in adults aged 60 and older. The study will assess the vaccine’s safety and how well it helps the body develop an immune response against both viruses.
Fast Facts
Have not received a COVID-19 or influenza vaccination within the past 6 months
Ages 60+
Compensation
may be available for time and travel
Conducted in
Manchester, UK
Additional Information
This clinical trial aims to evaluate the safety of an investigational vaccine designed to protect against both COVID-19 and seasonal influenza. Researchers will study how well the vaccine produces an immune response against both viruses and monitor participants’ health following vaccination.
You may be eligible for this trial if you meet the following criteria.
- Ages 60+
- Have not received a COVID-19 or influenza vaccination, or had a confirmed COVID-19 or influenza infection, within the past 6 months
- In generally good health
- Able to attend in-person clinical trial visits
If you are eligible and choose to participate, you may be asked to:
Complete a screening: Speak with the research team by phone and attend a clinic visit to review your medical history, vaccination history, and overall health to determine whether you are eligible.
Attend a vaccination visit: Receive the study vaccination assigned to you according to the study design.
Attend follow-up visits: Visit the study site for health assessments and to monitor any reactions or side effects.
Complete follow-up calls: Speak with the research team by phone to share updates about your health and provide additional trial information.
Participation may involve up to three in-person clinic visits and up to four follow-up phone calls over approximately 12 months.
Study locations include Cardiff, Glasgow, the Midlands, and Manchester. You should be able to travel to a participating trial site for in-person visits.
Compensation for time and reimbursement of reasonable travel expenses may be available to eligible participants. The study team will explain the applicable arrangements before participation.
There is no cost for you to participate in our clinical trial.